|
Market Closed -
Athens S.E.
07:46:33 17/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.564 EUR | +0.26% |
|
+0.26% | +61.24% |
| 25/06 | Lavipharm S.A. announces Annual dividend, payable on July 24, 2026 | CI |
| 28/05 | Lavipharm Q1 earnings before tax from continuing operations EUR1.41 million, up 28.6% Y/Y | RE |
| Market Cap | 27Cr 31Cr 25Cr 23Cr 43Cr 2.95TCr 43Cr 293Cr 114.81Cr 1.48TCr 115.86Cr 113.35Cr 4.92TCr | P/E 2024 |
14.9x | P/E 2025 | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 29Cr 34Cr 27Cr 25Cr 47Cr 3.25TCr 48Cr 322.33Cr 126.31Cr 1.63TCr 127.46Cr 124.7Cr 5.41TCr | EV / Sales 2024 |
3.07x | EV / Sales 2025 | 3.04x |
| Free-Float |
39.31% | Yield 2024 |
2.52% | Yield 2025 | - |
| 1 day | +0.26% | ||
| 1 week | +0.26% | ||
| Current month | -1.64% | ||
| 1 month | +8.61% | ||
| 3 months | -1.14% | ||
| 6 months | +17.24% | ||
| Current year | +61.24% |
| 1 week | 1.54 | 1.59 | |
| 1 month | 1.4 | 1.65 | |
| Current year | 0.94 | 1.74 | |
| 1 year | 0.76 | 1.74 | |
| 3 years | 0.58 | 1.74 | |
| 5 years | 0.35 | 2.22 | |
| 10 years | 0.16 | 2.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 01/12/2021 | |
Ligia Panaitescu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | 76 | - | |
Minas G. Tanes
CHM | Chairman | 86 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/02/25 | Buy | Chief Financial Officer | 20,000 | 0.0119% | ||
| 27/05/23 | Sell | 35,434 | 0.0189% | |||
| 28/03/23 | Buy | Chief Financial Officer | 23,455 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | +0.26% | +90.96% | +120.90% | 31Cr | ||
| -2.49% | -3.24% | +14.66% | +64.56% | 4.84TCr | ||
| -0.12% | -5.43% | +52.28% | +115.90% | 3.97TCr | ||
| -1.28% | -2.21% | -8.47% | +15.11% | 1.23TCr | ||
| -0.33% | +1.55% | +14.43% | +72.12% | 1.18TCr | ||
| -0.58% | -0.77% | +29.90% | +141.59% | 906.17Cr | ||
| 0.00% | +1.64% | +22.99% | +39.94% | 756.57Cr | ||
| -0.88% | +1.18% | +40.97% | -13.86% | 717.59Cr | ||
| +0.46% | +2.19% | +13.91% | +192.06% | 684.21Cr | ||
| +0.63% | -2.53% | -30.10% | +23.84% | 576.86Cr | ||
| Average | -0.43% | +0.29% | +24.15% | +77.22% | 1.49TCr | |
| Weighted average by Cap. | -1.00% | -1.22% | +23.78% | +78.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.29Cr 6.13Cr 4.97Cr 4.52Cr 8.51Cr 586.39Cr 8.62Cr 58Cr 23Cr 293.78Cr 23Cr 23Cr 977.25Cr | 6.26Cr 7.25Cr 5.87Cr 5.35Cr 10Cr 693.14Cr 10Cr 69Cr 27Cr 347.26Cr 27Cr 27Cr 1.16TCr |
| Net income | 89.82L 1.04Cr 84.27L 76.75L 1.44Cr 99Cr 1.46Cr 9.88Cr 3.87Cr 50Cr 3.91Cr 3.82Cr 165.79Cr | 59.86L 69.34L 56.16L 51.15L 96.18L 66Cr 97.51L 6.58Cr 2.58Cr 33Cr 2.6Cr 2.55Cr 110.49Cr |
| Net Debt | 2.83Cr 3.28Cr 2.66Cr 2.42Cr 4.55Cr 313.82Cr 4.62Cr 31Cr 12Cr 157.22Cr 12Cr 12Cr 522.99Cr | 2.67Cr 3.09Cr 2.5Cr 2.28Cr 4.29Cr 295.41Cr 4.34Cr 29Cr 11Cr 148Cr 12Cr 11Cr 492.32Cr |
Employees
285
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | €1.564 | +0.26% | 8,975 |
| 14/26/14 | €1.560 | 0.00% | 5,223 |
| 13/26/13 | €1.560 | -0.64% | 25,588 |
| 12/26/12 | €1.570 | +0.26% | 9,742 |
| 11/26/11 | €1.566 | +0.38% | 37,104 |
- Stock Market
- Stocks
- LAVI Stock
Select your edition
All financial news and data tailored to specific country editions
















